Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
OBJECTIVE
To provide an expert review of the clinical management of hypoactive sexual desire disorder.


METHODS
The importance of diagnosing and providing therapeutic management for hypoactive sexual desire disorder will be explained with a case scenario which is resolved by drawing on original trial publications and meta-analyses published in English.


RESULTS
Hypoactive sexual desire disorder (HSDD) is highly prevalent (9-16%) and has a strong impact on the quality of life of both women and their partners. Medical and sexual history, physical and laboratory examinations as well as validated questionnaires will help us make an accurate diagnosis. Treatment should begin by focusing on lifestyle and psychosexual therapy. Women randomized to oestrogen-testosterone transdermal patch combination or testosterone transdermal patch alone reported significantly increased frequency of satisfying sexual activity (p<0.05). Hormonal treatment with oestrogen and testosterone or with testosterone alone should be personalized, as should follow-up.


CONCLUSIONS
Guidelines for the medical management of hypoactive sexual desire disorder are now available and this starts by understanding the importance of this disorder and knowing that accurate diagnosis and treatment options exist.
Palacios
Santiago
S
Palacios Institute of Woman's Health, Antonio Acuña, 9, 28009 Madrid, Spain. ipalacios@institutopalacios.com
Graziottin
Alessandra
A
D003376:Counseling; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D013739:Testosterone / Q000627:therapeutic use
D004967:Estrogens; D013739:Testosterone